A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Metastasis
Interventions: DRUG: Fulvestrant|DRUG: Tamoxifen
Sponsor: AstraZeneca